Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Hims Hers Health Inc (HIMS)
Top performer
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/07/2025: HIMS (5-star) is a WEAK-BUY. BUY since 8 days. Profits (-15.30%). Updated daily EoD!
Upturn Star Rating
Outstanding Performance
These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.
Number of Analysts
13 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $50.45
1 Year Target Price $50.45
| 4 | Strong Buy |
| 1 | Buy |
| 6 | Hold |
| 1 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 175.34% | Avg. Invested days 30 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 08/07/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 12.55B USD | Price to earnings Ratio 70.04 | 1Y Target Price 50.45 |
Price to earnings Ratio 70.04 | 1Y Target Price 50.45 | ||
Volume (30-day avg) 13 | Beta 2.09 | 52 Weeks Range 13.47 - 72.98 | Updated Date 08/7/2025 |
52 Weeks Range 13.47 - 72.98 | Updated Date 08/7/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.73 |
Earnings Date
Report Date 2025-08-04 | When - | Estimate 0.1537 | Actual 0.2894 |
Profitability
Profit Margin 9.61% | Operating Margin (TTM) 4.91% |
Management Effectiveness
Return on Assets (TTM) 6.94% | Return on Equity (TTM) 41.88% |
Valuation
Trailing PE 70.04 | Forward PE 96.15 | Enterprise Value 11456154175 | Price to Sales(TTM) 6.23 |
Enterprise Value 11456154175 | Price to Sales(TTM) 6.23 | ||
Enterprise Value to Revenue 5.69 | Enterprise Value to EBITDA 74.02 | Shares Outstanding 217642000 | Shares Floating 196503684 |
Shares Outstanding 217642000 | Shares Floating 196503684 | ||
Percent Insiders 11.02 | Percent Institutions 81.84 |
Upturn AI SWOT
Hims Hers Health Inc
Company Overview
History and Background
Hims & Hers Health, Inc. was founded in 2017. Initially focused on men's wellness products, it quickly expanded to include women's health services. The company went public via SPAC in January 2021.
Core Business Areas
- Telehealth Services: Offers virtual consultations with licensed healthcare providers for a range of conditions, including dermatology, mental health, and sexual health.
- Personalized Medications: Provides access to prescription medications, often customized to individual patient needs, through its affiliated pharmacies.
- Over-the-Counter Products: Sells a variety of over-the-counter health and wellness products, including supplements, skincare, and hair care items.
Leadership and Structure
Andrew Dudum is the CEO. The company has a traditional corporate structure with departments such as marketing, technology, operations, and finance.
Top Products and Market Share
Key Offerings
- Erectile Dysfunction Treatments: Offers sildenafil and tadalafil, generic versions of Viagra and Cialis. Competitors include Roman (GetRoman Inc). Market share data is difficult to obtain due to the fragmented nature of the online pharmacy market, but Hims & Hers are major players in this space. Revenue not publicly broken down by specific product.
- Hair Loss Treatments: Offers finasteride and minoxidil for hair loss. Competitors include Keeps (Thirty Madison). Similar to ED treatments, specific market share is hard to pinpoint, however hair loss is a key revenue driver for the company. Revenue not publicly broken down by specific product.
- Mental Health Services: Provides access to therapy and medication for anxiety and depression. Competitors include Talkspace (TALK) and Teladoc (TDOC). Revenue not publicly broken down by specific product.
- Skincare Products: Offers customized skincare treatments for acne and aging. Competitors include Curology. Revenue not publicly broken down by specific product.
Market Dynamics
Industry Overview
The telehealth market is experiencing rapid growth, driven by increasing access to technology, rising healthcare costs, and a growing demand for convenient healthcare solutions. The market is fragmented with both large established players and newer direct to consumer companies.
Positioning
Hims & Hers is positioned as a direct-to-consumer telehealth provider focused on providing convenient and affordable access to healthcare for common conditions. Their competitive advantages include strong branding, a vertically integrated supply chain, and a focus on personalized treatments.
Total Addressable Market (TAM)
The global telehealth market is estimated to reach hundreds of billions of dollars. Hims & Hers is well-positioned to capture a significant portion of this market, focusing on specific niches like men's and women's health.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Direct-to-consumer model
- Vertically integrated supply chain
- Personalized treatments
- Growing subscriber base
Weaknesses
- Reliance on prescription medications
- Marketing Costs
- Negative Profit Margins
- Competition from established healthcare providers
Opportunities
- Expanding into new therapeutic areas
- Partnering with healthcare systems
- Increasing international presence
- Developing new technologies
- Acquiring smaller telehealth companies
Threats
- Increased competition
- Changes in regulations
- Economic downturn
- Data security breaches
- Adverse drug reactions
Competitors and Market Share
Key Competitors
- Teladoc Health Inc (TDOC)
- GoodRx Holdings Inc (GDRX)
- Amazon.com Inc (AMZN)
- Thirty Madison (Private)
Competitive Landscape
Hims & Hers competes with both established telehealth providers and newer direct-to-consumer companies. Its strengths include its strong brand and vertically integrated supply chain. Its weaknesses include its reliance on prescription medications and its lack of profitability.
Growth Trajectory and Initiatives
Historical Growth: The company has experienced rapid revenue growth since its inception.
Future Projections: Analysts project continued revenue growth, but profitability is expected to remain a challenge.
Recent Initiatives: Recent initiatives include expanding into new therapeutic areas, partnering with healthcare providers, and launching new products.
Summary
Hims & Hers is a rapidly growing telehealth company with a strong brand and a direct-to-consumer model. It has experienced significant revenue growth, but profitability remains a challenge. Key strengths include their brand and vertical integration, while reliance on marketing spending and prescription drugs may limit expansion. The company should focus on reducing expenses and expanding service offerings.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Analyst Reports
- Industry Research Reports
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered financial advice. Market share data is approximate and based on available information. Invest at your own risk.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Hims Hers Health Inc
Exchange NYSE | Headquaters San Francisco, CA, United States | ||
IPO Launch date 2019-09-13 | Co-Founder, Chairman & CEO Mr. Andrew Dudum | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 1637 | Website https://www.hims.com |
Full time employees 1637 | Website https://www.hims.com | ||
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.